• Return to Headlines

Pacira Pharmaceu has the Highest Future Earnings Growth in the Pharmaceuticals Industry (PCRX, AMPH, AKRX, SUPN, HZNP)

By Shiri Gupta

Below are the three companies in the Pharmaceuticals industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and relative value. Higher EPS growth generally justifies higher earnings multiples.

Pacira Pharmaceu ranks highest with a future earnings growth of 311.8%. Amphastar Pharma is next with a future earnings growth of 215.1%. Akorn Inc ranks third highest with a future earnings growth of 46.4%.

Supernus Pharmac follows with a future earnings growth of 35.2%, and Horizon Pharma P rounds out the top five with a future earnings growth of 21.8%.

SmarTrend recommended that subscribers consider buying shares of Pacira Pharmaceu on September 25th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $39.26. Since that recommendation, shares of Pacira Pharmaceu have risen 17.7%. We continue to monitor Pacira Pharmaceu for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest future earnings growth pacira pharmaceu amphastar pharma akorn inc supernus pharmac horizon pharma p